ClinicalTrials.gov
ClinicalTrials.gov Menu

Estimation of Osteoporosis' Prevalence in France: Pilot Study in the Department of the Alpes-Maritimes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00821925
Recruitment Status : Completed
First Posted : January 14, 2009
Last Update Posted : December 8, 2011
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Nice

Brief Summary:
The purpose of this study is to estimate Osteoporosis' prevalence in France and is a pilot study in the Department of the Alpes-Maritimes.

Condition or disease Intervention/treatment Phase
Osteoporosis Procedure: bone densitometry Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 800 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Screening
Official Title: Estimation of Osteoporosis' Prevalence in France: Pilot Study in the Department of the Alpes-Maritimes
Study Start Date : December 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Osteoporosis
U.S. FDA Resources


Intervention Details:
    Procedure: bone densitometry
    All patients do a bone densitometry after the inclusion.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   50 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patient member of Caisse Primaire d'Assurance Maladie

Exclusion Criteria:

  • Patient incapable of understanding the questionary

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00821925


Locations
France
Department of Rheumatology
Nice, France, 06002
Sponsors and Collaborators
Centre Hospitalier Universitaire de Nice
Investigators
Principal Investigator: Liana Euller-Ziegler, PU-PH Department of Rheumatology

Responsible Party: Centre Hospitalier Universitaire de Nice
ClinicalTrials.gov Identifier: NCT00821925     History of Changes
Other Study ID Numbers: 06-PP-04
First Posted: January 14, 2009    Key Record Dates
Last Update Posted: December 8, 2011
Last Verified: January 2009

Keywords provided by Centre Hospitalier Universitaire de Nice:
osteoporosis

Additional relevant MeSH terms:
Osteoporosis
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases
Metabolic Diseases